Agfa-Gevaert NV (AGFB) Fair Value & Analysis
Industrials · BE · Market cap €68.9M
Fair value as of: Jun 24, 2026
From 14 valuation models · updated 5 days ago
Share price −4.5% over the past month.
Price vs Fair Value (12 months)
12‑month range €0.4224 – €1.18 · fair‑value band €2.06 – €4.78 · the €0.4315 price screens below the €3.17 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Agfa-Gevaert NV (AGFB) currently trades at €0.4315, while our model-based Fair Value estimate is €3.17 — implying the stock looks roughly 634.6% undervalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, Agfa-Gevaert NV generated revenue of €1.1B at a net margin of -5.8%. Revenue declined 2.5% year over year. It earns a return on equity of -18.2%. Net debt stands at €78.0M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems in Belgium and internationally. The company provides healthcare's enterprise imaging platform. It also offers printers, inks, and software for sign and display and packaging printing companies; inkjet inks and fluids for various industrial inkjet applications, such as signs, displays, billboards, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry; and printable synthetic papers and films for graphics, non-destructive testing, aerial photography, and printed circuit board production. In addition, it provides analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing softwar…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Agfa-Gevaert NV reported revenue of €1.1B in FY2025 versus €1.8B in FY2021, a compound −11.4%/yr. Reported net income was −€71.0M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| GE Vernova Inc GEV | $1,035 | $131.95 | -87% |
| SIEGY SIEGY | $155.06 | $89.54 | -42% |
| SMAWF SMAWF | $307.12 | $176.28 | -43% |
| SMNS SMNS | C$31.76 | C$22.85 | -28% |
| SIE SIE | €269.80 | €161.17 | -40% |
| Schneider Electric S.E. SBGSF | $334.00 | $148.44 | -56% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Agfa-Gevaert NV (AGFB) undervalued?
What is the fair value of AGFB?
What is the quality score of AGFB?
What is the revenue of Agfa-Gevaert NV (AGFB)?
What is the net profit margin of AGFB?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.